125 related articles for article (PubMed ID: 8009195)
21. DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy.
Di Silverio F; D'Eramo G; Buscarini M; Sciarra A; Casale P; Di Nicola S; Loreto A; Seccareccia F; De Vita R
Eur Urol; 1996; 30(3):316-21. PubMed ID: 8931963
[TBL] [Abstract][Full Text] [Related]
22. Value of nuclear DNA ploidy patterns in patients with prostate cancer after radical prostatectomy.
Wirth MP; Müller HA; Manseck A; Müller J; Frohmüller HG
Eur Urol; 1991; 20(3):248-52. PubMed ID: 1823048
[TBL] [Abstract][Full Text] [Related]
23. [Flow cytometry in prostate cancer. Evaluation of its feasibility for biopsy specimens and correlation with grading].
Ferrara G; Monaco R; Capasso A; Bellomo PF; Fruttero A; Pugno F; Nappi O; Ruà S
Pathologica; 1998 Feb; 90(1):14-9. PubMed ID: 9628974
[TBL] [Abstract][Full Text] [Related]
24. DNA ploidy: early malignant lesions.
Lieber MM
J Cell Biochem Suppl; 1992; 16H():44-6. PubMed ID: 1289672
[TBL] [Abstract][Full Text] [Related]
25. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
[TBL] [Abstract][Full Text] [Related]
26. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
[TBL] [Abstract][Full Text] [Related]
27. Biopsy Gleason score: how does it correlate with the final pathological diagnosis in prostate cancer?
Fernandes ET; Sundaram CP; Long R; Soltani M; Ercole CJ
Br J Urol; 1997 Apr; 79(4):615-7. PubMed ID: 9126095
[TBL] [Abstract][Full Text] [Related]
28. Intratumor heterogeneity of DNA ploidy and correlations with clinical stage and histologic grade in prostate cancer.
Kucuk O; Demirer T; Gilman-Sachs A; Taw I; Mangold M; Singh S; Westerman MP
J Surg Oncol; 1993 Nov; 54(3):171-4. PubMed ID: 8412173
[TBL] [Abstract][Full Text] [Related]
29. Prostatic intraepithelial neoplasia in surgical resections: relationship to coexistent adenocarcinoma and atypical adenomatous hyperplasia of the prostate.
Skjørten FJ; Berner A; Harvei S; Robsahm TE; Tretli S
Cancer; 1997 Mar; 79(6):1172-9. PubMed ID: 9070495
[TBL] [Abstract][Full Text] [Related]
30. DNA-ploidy as prognostic factor in prostatic carcinoma.
Haugen OA; Mjølnerød O
Int J Cancer; 1990 Feb; 45(2):224-8. PubMed ID: 2303288
[TBL] [Abstract][Full Text] [Related]
31. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
[TBL] [Abstract][Full Text] [Related]
32. Deoxyribonucleic acid ploidy status as no basis for pathologic stage prediction in clinically resectable prostate cancer.
Egawa S; Satoh T; Iwamura M; Aihara M; Kuwao S; Uchida T; Koshiba K
Urology; 1996 Apr; 47(4):548-52. PubMed ID: 8638366
[TBL] [Abstract][Full Text] [Related]
33. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications.
Ruijter ET; van de Kaa CA; Schalken JA; Debruyne FM; Ruiter DJ
J Pathol; 1996 Nov; 180(3):295-9. PubMed ID: 8958808
[TBL] [Abstract][Full Text] [Related]
34. Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group.
van den Ouden D; Tribukait B; Blom JH; Fossa SD; Kurth KH; ten Kate FJ; Heiden T; Wang N; Schroder FH
J Urol; 1993 Aug; 150(2 Pt 1):400-6. PubMed ID: 8326563
[TBL] [Abstract][Full Text] [Related]
35. Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer.
Frankfurt OS; Chin JL; Englander LS; Greco WR; Pontes JE; Rustum YM
Cancer Res; 1985 Mar; 45(3):1418-23. PubMed ID: 3971384
[TBL] [Abstract][Full Text] [Related]
36. Relationship of DNA content to conventional prognostic factors in clinically localised carcinoma of the prostate.
Ritchie AW; Dorey F; Layfield LJ; Hannah J; Lovrekovich H; deKernion JB
Br J Urol; 1988 Sep; 62(3):245-60. PubMed ID: 3191338
[TBL] [Abstract][Full Text] [Related]
37. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens.
Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H
Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653
[TBL] [Abstract][Full Text] [Related]
38. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
Qian J; Bostwick DG
Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
[TBL] [Abstract][Full Text] [Related]
39. Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.
Peller PA; Young DC; Marmaduke DP; Marsh WL; Badalament RA
Cancer; 1995 Jan; 75(2):530-8. PubMed ID: 7529129
[TBL] [Abstract][Full Text] [Related]
40. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
